Medicare Enrolled
Dr. David Albala, M.D.
Urology Physician · Syracuse, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Albala from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Albala?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Albala
Dr. David Albala is an urology physician in Syracuse, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Albala performed 8,559 Medicare services across 2,089 unique beneficiaries.
Between the years covered by Open Payments, Dr. Albala received a total of $202,376 from 60 pharmaceutical and/or device companies across 444 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Albala is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 10% volume in NY
$202,376 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,559
Medicare services
Top 10% in NY for urology physician
2,089
Unique beneficiaries
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~450 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
3,900 | $0 | $2 |
| BCG treatment for bladder cancer | 1,850 | $2 | $6 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
699 | $2 | $12 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
462 | $89 | $259 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
252 | $60 | $173 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
230 | $8 | $11 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
224 | $48 | $124 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
133 | $23 | $130 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
133 | $47 | $123 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
99 | $172 | $703 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
60 | $8 | $46 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
58 | $35 | $94 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
54 | $19 | $46 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
45 | $110 | $384 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
44 | $68 | $215 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
35 | $230 | $1,028 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
30 | $40 | $146 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
29 | $97 | $1,256 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
29 | $48 | $184 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
28 | $189 | $675 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
27 | $76 | $271 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
25 | $62 | $180 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
24 | $3 | $7 |
| Injection procedure for imaging of kidney and ureter through already existing skin access using imaging guidance with review by radiologist | 18 | $25 | $835 |
| Complex kidney stone removal with imaging guidance A surgical procedure to remove kidney stones using imaging technology to guide the process. |
17 | $869 | $3,184 |
| Simple change of bladder tube | 16 | $73 | $222 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
14 | $341 | $1,933 |
| Ultrasound of scrotum An imaging test that uses sound waves to create pictures of the scrotum and its contents. It helps evaluate the testicles and surrounding structures. |
13 | $47 | $120 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
11 | $11 | $205 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.9% high complexity
50.0% medium
49.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$202,376
Total received (2018-2024)
Avg $28,911/year across 7 years
Top 2% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
444
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$100,882 (49.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$91,749 (45.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,746 (4.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$27,133
2023
$33,887
2022
$15,363
2021
$26,218
2020
$11,458
2019
$13,407
2018
$74,910
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PROGENICS PHARMACEUTICALS, INC.
$13,067
Siemens Medical Solutions USA, Inc.
$5,942
Janssen Scientific Affairs, LLC
$3,385
Edap Technomed Inc
$1,772
UROGEN PHARMA, INC.
$1,619
Myriad Genetic Laboratories, Inc.
$545
PROCEPT BioRobotics Corporation
$202
Applied Medical Resources Corporation
$188
Boston Scientific Corporation
$127
Antares Pharma, Inc.
$56
Janssen Biotech, Inc.
$39
Olympus America Inc.
$28
Astellas Pharma US Inc
$25
Endo Pharmaceuticals Inc.
$23
COLOPLAST CORP
$22
ABBVIE INC.
$21
Merck Sharp & Dohme LLC
$20
Ferring Pharmaceuticals Inc.
$19
Endo USA, Inc.
$19
BIOPROTECT MEDICAL, INC.
$14
Top 3 companies account for 82.5% of 2024 payments
All-time payments by company (2018-2024) ›
Avadel Specialty Pharmaceuticals, LLC
$50,888
Progenics Pharmaceuticals, Inc.
$26,373
Boston Scientific Corporation
$26,276
Janssen Scientific Affairs, LLC
$13,851
PROGENICS PHARMACEUTICALS, INC.
$13,067
BOSTON SCIENTIFIC CORPORATION
$8,624
NxThera, Inc.
$7,695
Blue Earth Diagnostics Limited
$6,993
Janssen Biotech, Inc.
$6,486
Siemens Medical Solutions USA, Inc.
$5,942
Applied Medical Resources Corporation
$5,896
Intuitive Surgical, Inc.
$4,976
Foundation Medicine, Inc.
$4,033
Janssen Global Services, LLC
$3,282
Myovant Sciences Inc.
$3,195
Amgen Inc.
$2,075
Edap Technomed Inc
$1,772
UROGEN PHARMA, INC.
$1,714
Teleflex LLC
$1,333
Provepharm Inc.
$1,142
PROCEPT BioRobotics Corporation
$1,093
Myriad Genetic Laboratories, Inc.
$969
C. R. Bard, Inc. & Subsidiaries
$890
Astellas Pharma US Inc
$778
Novo Nordisk Inc
$595
Bayer HealthCare Pharmaceuticals Inc.
$259
PFIZER INC.
$248
Dendreon Pharmaceuticals LLC
$165
GENZYME CORPORATION
$144
TOLMAR Pharmaceuticals, Inc.
$127
ACCORD HEALTHCARE, INC.
$106
PALETTE LIFE SCIENCES, INC.
$105
Antares Pharma, Inc.
$104
Merck Sharp & Dohme LLC
$103
C. R. BARD, INC. & SUBSIDIARIES
$98
UroGen Pharma, Inc.
$90
Endo Pharmaceuticals Inc.
$83
Sumitomo Pharma America, Inc.
$82
Olympus America Inc.
$72
NeoTract Inc.
$60
AbbVie, Inc.
$54
AstraZeneca Pharmaceuticals LP
$50
Mission Pharmacal Company
$43
Coloplast Corp
$43
Ethicon US, LLC
$40
UROVANT SCIENCES INC
$38
Supernus Pharmaceuticals, Inc.
$33
Ferring Pharmaceuticals Inc.
$31
Laborie Medical Technologies Corp.
$30
Travere Therapeutics, Inc.
$26
Palette Life Sciences, Inc.
$25
SUN PHARMACEUTICAL INDUSTRIES INC.
$24
Agiliti Surgical, Inc.
$23
COLOPLAST CORP
$22
ABBVIE INC.
$21
Endo USA, Inc.
$19
AbbVie Inc.
$19
180 Medical, Inc.
$18
Otsuka America Pharmaceutical, Inc.
$17
BIOPROTECT MEDICAL, INC.
$14
Top 3 companies account for 51.2% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AMS 700 · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Androgel · AquaBeam Robotic System · Axumin · BIOPROTECT BALLOON IMPLANT SYSTEM · BLUDIGO · BOTOX · BRACAnalysis CDx · Balversa · Biograph Horizon-3R · CAMCEVI · Coloplast TFL Drive · Da Vinci Surgical System · ELIGARD · ERLEADA · Erleada · FIRMAGON · FOUNDATIONACT · GELPOINT V-PATH · GEMTESA · GENERAL BPH · GENERAL ONCOLOGY · GENERAL BPH · GENERAL THERAPIES · GENERAL - BPH · GENERAL THERAPIES · GENTLECATH · GREENLIGHT · GelPOINT Advanced Access Platform · General - BPH · General - Oncology · JELMYTO · JEVTANA · JYNARQUE · KEYTRUDA · LYNPARZA · LithoVue · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Noctiva · ORGOVYX · PROLARIS · PROVENGE · PYLARIFY · Porges Coloplast · Prolaris · Prolia · REZUM · Rezum · SPACEOAR · SPACEOAR VUE · STAPLER · Sonablate · SpaceOAR System · SpaceOAR VUE System - 10mL · THERAPIES · TOVIAZ · Thiola · UROLIFT · Uribel · UroLift · Urocit-K · VESICARE · VISTASEAL · VOYANT · Voyant fine fusion device · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · ZYTIGA · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (50%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for urology physician in NY.
Geographic Context
Urology physicians within 10 mi
61
Per 100K population
12.9
County median income
$74,740
Nearest hospital
CROUSE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Albala is a mixed practice specialist, with above-average Medicare volume (top 10% in NY), with speaking/promotional industry engagement in the top 2% of NY peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Albala experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Albala performed 3,900 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Albala receive payments from pharmaceutical companies?
Yes. Dr. Albala received a total of $202,376 from 60 companies across 444 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Albala's costs compare to other urology physicians in Syracuse?
Dr. Albala's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Albala) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Syracuse
Browse urology physicians in Syracuse ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NY
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NY
Which NY urology physicians receive the most from drug and device companies.
By company
Avadel Specialty Pharmaceuticals, LLC Payments to Doctors
See all physicians who received payments from Avadel Specialty Pharmaceuticals, LLC.
By company
Progenics Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Progenics Pharmaceuticals, Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology